SCHEMBL18687

SCHEMBL18687

C1C[N]CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180005 0.90
SCHEMBL285073 0.88
SCHEMBL235202 0.79
SCHEMBL3009 0.79
SCHEMBL600790 0.76 CXCR4 (0.53)
SCHEMBL1782168 0.73 CXCR4 (0.41)
SCHEMBL10036 0.73
SCHEMBL1779850 0.73 CXCR4 (0.50)
SCHEMBL567977 0.71 ALDH1A1 (0.56)
SCHEMBL674050 0.69 CXCR4 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6636 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226132-A1 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2024-07-11 US claimed
EP-3930838-B1 N-(PYRIDINYL)ACETAMIDE DERIVATIVES AS P300/CBP HAT INHIBITORS AND METHODS FOR THEIR USE CONSTELLATION PHARMACEUTICALS INC (US) 2024-07-10 EP claimed
CN-118307518-A Polycyclic PARP selective inhibitors 轩竹生物科技股份有限公司 2024-07-09 CN claimed
CN-118302423-A Amine compound and use thereof 石药集团中奇制药技术(石家庄)有限公司 2024-07-05 CN claimed
WO-2024139427-A1 CATALYST SYSTEM AND METHOD FOR CARBONYLATION REACTION 浙江新和成股份有限公司 2024-07-04 WO claimed
WO-2024141011-A1 COMPLEMENT FACTOR B INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 深圳晶泰科技有限公司 2024-07-04 WO claimed
CN-113727756-B P300/CBP HAT inhibitors and methods of use thereof 星座制药公司 2024-07-02 CN claimed
EP-4389738-A1 SOS1 INHIBITOR AND USE THEREOF Kanaph Therapeutics Inc. (KR) 2024-06-26 EP claimed
CN-118203585-A Pharmaceutical use of ENPP1 inhibitors 上海翊石医药科技有限公司 2024-06-18 CN claimed
CN-113493471-B Heteroaromatic kinase inhibitors 山东轩竹医药科技有限公司 2024-06-11 CN claimed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO claimed
EP-0157762-B1 NEW SUBSTITUTED PIPERIDINOGUANIDINES, PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOUCHARA S.A. (FR) 1990-08-08 EP claimed
US-4940789-A 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents AMERICAN HOME PRODUCTS CORPORATION (US) 1990-07-10 US claimed
EP-0102239-B1 AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES IN THE PREPARATION OF CARBAPENEM ANTIBIOTICS SANKYO COMPANY LIMITED (JP) 1987-10-14 EP claimed
EP-0175363-A2 4,5-Dihydro-3(2H)-pyridazinones, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1986-03-26 EP claimed
US-4576749-A 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones E. R. SQUIBB & SONS, INC. (US) 1986-03-18 US claimed
EP-0138407-A1 Azetidinones E.R. Squibb &amp; Sons, Inc. (US) 1985-04-24 EP claimed
EP-0102239-A1 Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics SANKYO COMPANY LIMITED (JP) 1984-03-07 EP claimed
US-4113867-A ANTHELMINTICS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US claimed
US-4108994-A 5-THIAZOLE-METHANE-AMINES, AND THEIR USE AS ANTILIPOLYTICS ROUSSEL UCLAF (FR) 1978-08-22 US claimed